Site US2778 John B. Amos Cancer Center — Columbus, Georgia

Site US2778 John B. Amos Cancer Center is a clinical research site located in Columbus, Georgia, United States 31904.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US2778 John B. Amos Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma.

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US2778 John B. Amos Cancer Center?

Site US2778 John B. Amos Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US2778 John B. Amos Cancer Center conducted?

Site US2778 John B. Amos Cancer Center has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma.

Is Site US2778 John B. Amos Cancer Center accredited by Crixeo Health?

Site US2778 John B. Amos Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US2778 John B. Amos Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.